1. Home
  2. CNSP

CNSP

CNS Pharmaceuticals Inc.

Logo CNS Pharmaceuticals Inc.

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

as 04-19-2024 11:20am EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

CNS Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. It is involved in the development of Berubicin, which is a therapy for the treatment of glioblastoma. Glioblastomas are tumors that arise from astrocytes, which are star-shaped cells that make up the supportive tissue of the brain.

Founded: 2017 Country:
United States
United States
Employees: 3 City: HOUSTON
Market Cap: 2.2M IPO Year: 2019
Target Price: N/A AVG Volume (30 days): 438.3K
Analyst Decision: N/A Number of Analysts: N/A
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -5.00 EPS Growth: N/A
52 Week Low/High: $0.22 - $4.40 Next Earning Date: 05-13-2024
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

Share on Social Networks: